Editorial: Seizures, epilepsy, and vascular malformations

Neurology

Volumn 76, Issue 18, 2011, Pages 1540-1541

  Hauser, W Allen ^a,b   Mohr, J P ^a  

^a Columbia University ^*  (United States)

^b Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BRAIN INFECTION; CAVERNOUS HEMANGIOMA; CLINICAL STUDY; DISEASE CONTROL; EDITORIAL; EPILEPSY; NEUROLOGIC DISEASE; OCCLUSIVE STROKE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; SEIZURE; STROKE; TRAUMATIC BRAIN INJURY; UNITED KINGDOM; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMANGIOMA; HUMAN; NOTE; PREVALENCE;

EPILEPSY; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; PREVALENCE; PROGNOSIS; SEIZURES;

EID: 79955641276     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318219fb97     Document Type: Editorial

References (15)

1. Josephson CB, Leach J-P, Duncan R, et al. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology 2011;76:1548-1554.
2. Al-Shahi R, Bhattacharya JJ, Currie DG, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 2003;34:1163-1169. (Pubitemid 36547507)
3. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001;42:515-524. (Pubitemid 32322197)
4. Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence following a first unprovoked seizure: an extended follow-up. Neurology 1990;40:1163-1170. (Pubitemid 20244969)
5. Shinnar S, Berg AT, Moshe SL, et al. The risk for seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics 1996;98:216-225. (Pubitemid 26262133)
6. Haltiner AM, Temkin NR, Dikmen SS. Risk of seizure recurrence after the first late posttraumatic seizure. Arch Phys Med Rehabil 1997;8:835-840. (Pubitemid 27375089)
7. Osipov A, Koennecke HC, Hartmann A, et al. Seizures in cerebral arteriovenous malformations: type, clinical course, and medical management. Interv Neuroradiol 1997;3:37-41. (Pubitemid 27261270)
8. Marson AG, Al-Kharusi AM, Alwaidh M, et al, SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-1015. (Pubitemid 46436124)
9. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51:1069-1077.
10. Stavrou I, Baumgartner C, Frischer JM, et al. Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery 2008;63:888-896.
11. Baumann CR, Acciarri N, Bertalanffy H, et al. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia 2007;48: 559-556.
12. Callaghan BC, Anand K, Hesdorffer D, et al. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007;62:382-389. (Pubitemid 350105952)
13. Choi H, Heiman GA, Munger CH, et al. Seizure remission in adults with long-standing intractable epilepsy: an extended follow-up. Epilepsy Res 2011;3:115-119.
14. Stapf C, Mohr JP, Choi JH, Hartmann A, Mast H. Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol 2006; 19:63-68. (Pubitemid 43172707)
15. Crawford PM, West CR, Chadwick DW, Shaw MD. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 1986; 49:1-10. (Pubitemid 16155702)